1. Home
  2. Browse Decisions
  3. F.Supp.3d
  4. 570 F.Supp.3d
  5. 570 F.Supp.3d 100 (2021)
 

NIMBUS THERAPEUTICS, LLC v. CELGENE CORP.

21-cv-6850 (JSR).

570 F.Supp.3d 100 (2021)

NIMBUS THERAPEUTICS, LLC and Nimbus Lakshmi, Inc., Plaintiffs & Counter-Defendants, v. CELGENE CORP. and Bristol-Myers Squibb Co., Defendants & Counter-Claimants.

United States District Court, S.D. New York.

Signed November 8, 2021.

Attorney(s) appearing for the Case

Alicia Rubio-Spring , Goodwin Procter, LLP, Boston, MA, Andrew Lacy , Goodwin Procter LLP, District of Columbia, DC, Jeffrey A. Simes , Marshall Howard Fishman , Goodwin Procter, LLP, New York, NY, Arman Y. Oruc , Goodwin Procter LLP, Los Angeles, CA, for Plaintiffs & Counter-Defendants.

Devora Whitman Allon , Matthew Osborn Solum , Yosef J. Riemer , Jeffrey Ross Goldfine , Joseph Myer Sanderson , Kirkland & Ellis LLP, New York, NY, Amal El Bakhar , Kirkland and Ellis, New York City, NY, for Defendants & Counter-Claimants.

OPINION AND ORDER

Before the Court is the motion of Defendants and Counter-Claimants Celgene Corporation ("Celgene") and Bristol-Myers Squibb Company ("BMS") for a preliminary injunction. On October 14, 2021, the Court issued a short, "bottom-line" order granting Celgene and BMS's motion. That order preliminarily...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases